Clinical trial
NOX4, Mitochondria and Related Biomarkers in Autosomal Dominant Polycystic Kidney Disease
NCT04630613 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NOX4, Mitochondria and Related Biomarkers in Autosomal Dominant Polycystic Kidney Disease
- Lead sponsor
- Mayo Clinic
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 21, 2020
- Completion date
- January 31, 2027
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autosomal dominant polycystic kidney disease